CRISPR Therapeutics AG (CRSP): A Bull Case Theory

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this article, we will summarize the bulls’ thesis on CRSP. CRISPR Therapeutics AG (CRSP)'s share was trading at $40.97 as of March 18^th. CRSP’s trailing and forward P/E were 22.55 and 23.36 respectively according to Yahoo Finance.

[caption id="attachment_1202188" align="aligncenter" width="768"] A lab scientist peering into a microscope focused on gene editing technology.[/caption]

CRISPR Therapeutics (CRSP) is a pioneering biotech firm leveraging CRISPR gene...